申请人:Merck Sharp & Dohme Corp.
公开号:US20180051043A1
公开(公告)日:2018-02-22
The present invention relates to Phosphate Substituted Quinolizine Derivatives of Formula (I): and pharmaceutically acceptable salts or prodrug thereof, wherein X, Y, R
1
, R
2
, R
3
, R
4
, R
5
, R
9
and R
10
are as defined herein. The present invention also relates to compositions comprising at least one Phosphate Substituted Quinolizine Derivative, and methods of using the Phosphate Substituted Quinolizine Derivatives for treating or preventing HIV infection in a subject.